Life Science Investing Bristol Myers Squibb to Participate in Citi's 2025 Global Healthcare Conference 26 November
Life Science Investing Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Mantle Cell Lymphoma 24 November
